Medical Innovation in the Changing Healthcare Marketplace Conference Summary (2002) / Chapter Skim
Currently Skimming:
Appendix C: Keynote Speech: Encouraging High-Value Medical Innovation, Mark McClellan, Council of Economic Advisers
Appendix C: Keynote Speech: Encouraging High-Value Medical Innovation, Mark McClellan, Council of Economic Advisers
Pages 57-64
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 57... ...
The President in his campaign emphasized the need for better mechanisms for assuring that people get access to valuable new medical technologies and continuing to improve access to existing technologies. It is very clear from research done by participants in this conference that medical technology has contributed enormously to the improvements we have seen in health in this country in recent years, especially improvements in the length of life and the quality of life for older Americans.
|
From page 58... ...
Perhaps through better policy making we could encourage more innovation that leads to lower health care costs as well as improved health. In terms of the incentives for innovation that policy might influence there are three major areas.
|
From page 59... ...
Beyond that there are coverage decisions by the Center for Medicare and Medicaid Services (CMS, formerly the Health Care Financing Administration) , and other payers.
|
From page 60... ...
These technologies are widely used in some parts of the country and in some institutions. These variations seem much larger than can be explained for economic or clinical reasons, even though they may, in part, be due to differences in the preferences in the community and to differences in the skills of physicians and other health care providers in the community.
|
From page 61... ...
The NIH knows that the future of biomedical research depends critically on innovations in such underlying technologies as medical information systems. We are undertaking a review of whether there are better ways to fund some National Science Foundation research as well as to make sure it is coordinated with the expanded research enterprise at NIH.
|
From page 62... ...
I think there is a large body of literature indicating that longevity is also due in part to public health and primary prevention efforts. Yet the percentage of health care expenditures devoted to prevention has been estimated to be as low as 1 percent and no higher than 5 percent.
|
From page 63... ...
These are aimed at helping prevention regain a central place in our provision of health care and taking steps to try to make it easier for people in public programs, as well as in other insurance programs, to get the preventive care they need and to help them know when they need it. I did not mean to say that the use of medical technologies when diseases actually occur were the only, or even perhaps, the main contributor to improvements in health and the quality of life that we have seen in recent years.
|
From page 64... ...
We are trying to go forward establishing some uniform privacy standards as soon as practicable over the next couple of years in a way that is not overly burdensome for the health care industry to implement. Another impediment may be that the financial rewards for good information systems are not comparable to those in other industries.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.